Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classificação em ações #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Preço da ação
$0.12164306
Última sincronização: 2024-11-11
Valor de mercado
$38.53M
Variação (1 dia)
-4.14%
Variação (1 ano)
0.00%
País
AU
Negociar PharmAust Limited (PAA)

Categoria

Histórico de desdobramentos de ações de PharmAust Limited (PAA)
As ações PharmAust Limited (símbolo: PAA) passaram por um total de 4 desdobramentos.
O desdobramento mais recente ocorreu em Feb 20, 2019.
Uma ação PAA comprada antes de Nov 15, 2004 equivaleria hoje a 0.011443846153846 ações PAA.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
2019-02-20 551:500 x1.102 x0.011443846153846
2016-11-10 27:26 x1.0384615384615 x0.010384615384615
2015-10-30 1:20 x0.05 x0.01
2004-11-15 1:5 x0.2 x0.2
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH